Skip to main content
OpenTrials
Completed

NCT Number: NCT07238140

ATC vs PSV for Weaning in Patients With Respiratory Failure

Comparative study between automatic tube compensation and pressure support ventilation as a mode of weaning from mechanical ventilation in patients with respiratory failure

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

intensive care unit Department, Ain Shams University Hospital

Cairo, Cairo Governorate, 11835, Egypt

About this study

Mechanical ventilation is a cornerstone in the management of patients with acute respiratory failure, but prolonged dependence on the ventilator is associated with increased morbidity, mortality, and healthcare costs. Weaning, the process of transitioning a patient from mechanical ventilation to spontaneous breathing, is a critical phase that requires careful timing and appropriate methodology. The spontaneous breathing trial (SBT) is a widely used tool to assess weaning readiness, and several ventilatory modes have been developed to optimize this step. Among these, Automatic Tube Compensation (ATC) and Pressure Support Ventilation (PSV) are two commonly applied modes, each with distinct physiological principles.

ATC is designed to compensate precisely for the resistance imposed by the endotracheal tube, aiming to reproduce the normal work of breathing as if the patient were breathing without the artificial airway. In contrast, PSV provides a fixed level of pressure support throughout inspiration, which assists respiratory muscles and reduces the work of breathing but may not adapt dynamically to changes in flow or resistance. Although both modes are frequently used in intensive care units, evidence comparing their effectiveness in facilitating weaning and extubation success has been variable, with some studies suggesting physiological advantages of ATC but limited data on clinical outcomes.

his prospective randomized clinical trial was conducted to address this gap by directly comparing ATC and PSV as SBT modes in adult patients with acute respiratory failure receiving invasive mechanical ventilation. Patients were screened for weaning readiness using standardized clinical and physiological criteria and were subsequently randomized to undergo SBT with either ATC or PSV. Interventions were delivered following established ICU protocols to ensure safety and uniformity across groups.

Throughout the study, key respiratory and gas exchange parameters were monitored before and after the SBT to assess physiological responses to the two modes. Extubation decisions were based on predefined criteria to minimize variability in clinical judgment. Patients were followed for early post-extubation outcomes to evaluate the clinical impact of each mode on weaning success. The primary endpoint focused on improvement in oxygenation, while secondary endpoints included respiratory mechanics and post-extubation outcomes. The study adhered to ethical regulations, with written informed consent obtained prior to enrollment. By providing a structured comparison of these two modes, the study contributes to the evidence guiding optimal weaning strategies in adult critically ill patients, potentially improving clinical outcomes and optimizing ICU resource utilization.

Statistical analysis was performed using SPSS software (version 16.0; IBM Corp., Armonk, NY, USA). The required sample size was calculated a priori to provide 80% power to detect a clinically meaningful difference in the primary outcome at a two-sided significance level of 0.05. Continuous variables were expressed as mean ± standard deviation and compared between groups using appropriate parametric tests. Categorical variables were presented as frequencies and percentages, and analyzed using the Chi-square test or Fisher's exact test as indicated. A P value < 0.05 was considered statistically significant. Diagnostic accuracy was assessed using receiver operating characteristic (ROC) curve analysis, with calculation of sensitivity, specificity, positive predictive value, and negative predictive value.

The results of this completed study provide valuable clinical evidence regarding the optimal mode of spontaneous breathing trials in adult patients with acute respiratory failure. By comparing ATC and PSV, the study highlights differences in physiological responses and clinical outcomes between the two modes. These findings can help refine weaning protocols, support clinical decision-making, and contribute to improving extubation success rates and patient outcomes in intensive care settings. Moreover, the results may serve as a reference for future research and guideline development, particularly in resource-limited environments.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥18 years.
  • Admitted with acute respiratory failure (ARF).
  • On mechanical ventilation with Puritan-Bennett 840 ventilator for ≥24 hours.
  • Considered for weaning after improvement or resolution of underlying cause.
  • Fully conscious.
  • Minimal or no requirement for vasoactive drugs or sedation.
  • Adequate gas exchange (PaO₂/FiO₂ >200 at PEEP 5 cmH₂O and FiO₂ <0.5) Rapid shallow breathing index (RSBI) <105 breaths/min/L.

Exclusion criteria

  • Age <18 years.
  • Pre-existing chronic obstructive pulmonary disease (COPD).
  • Neuromuscular disorders.
  • Hemodynamic instability requiring high-dose vasoactive support.
  • Persistent altered level of consciousness.
  • Ongoing sedation.
  • Severe metabolic or electrolyte disturbances.
  • Morbid obesity (BMI ≥40 kg/m²).
  • Tracheostomy.
  • Pregnancy.
  • Refusal to participate by patient or legal guardian.

Treatment and study plan

Automatic tube compensation

Device

Automatic Tube Compensation (ATC) mode was applied at 100% using a Puritan-Bennett 840 ventilator during spontaneous breathing trials. This mode compensates for the additional resistance imposed by the endotracheal tube, thereby reducing patients' work of breathing and facilitating weaning from mechanical ventilation. Flow triggering was set at 1 L/min, with PEEP of 5 cmH₂O and FiO₂ < 0.5.

Other names: ATC

Pressure support ventilation

Device

Pressure Support Ventilation (PSV) was applied during spontaneous breathing trials using a Puritan-Bennett 840 ventilator. Patients breathed through the ventilator circuit with flow triggering set at 1 L/min, positive end-expiratory pressure (PEEP) of 5 cmH₂O, and fraction of inspired oxygen (FiO₂) < 0.5. Pressure support levels were adjusted to achieve a tidal volume of 6-8 mL/kg of predicted body weight

Other names: PSV

Primary outcomes

  1. Change in PaO₂/FiO₂ ratio (oxygenation index) during spontaneous breathing trial

    Time frame: Immediately before and at the end of the spontaneous breathing trial (SBT), assessed up to 2 hours

    The primary outcome was the change in the PaO₂/FiO₂ ratio measured immediately before and at the end of the spontaneous breathing trial (SBT). This parameter reflects the efficiency of oxygen exchange and is a validated predictor of weaning success. Higher improvements in the PaO₂/FiO₂ ratio indicate better respiratory function and a higher likelihood of successful extubation.

Secondary outcomes

  1. Change in Respiratory Rate to Tidal Volume Ratio (RR/VT)

    Time frame: Immediately before and at the end of the spontaneous breathing trial (SBT), assessed up to 2 hours

    Assessment of the rapid shallow breathing index (RR/VT) as a predictor of weaning success. Measurements will be taken at baseline and at the end of the spontaneous breathing trial to assess changes during weaning.

  2. Change in Oxygen Saturation (SpO₂)

    Time frame: Immediately before and at the end of the spontaneous breathing trial (SBT), assessed up to 2 hours

    Evaluation of oxygen saturation changes during the spontaneous breathing trial to assess the patient's oxygenation status.

  3. Change in Dynamic Compliance

    Time frame: Immediately before and at the end of the spontaneous breathing trial (SBT), assessed up to 2 hours

    Measurement of dynamic respiratory system compliance to assess lung mechanics before and after the spontaneous breathing trial.

  4. Change in Airway Resistance

    Time frame: Immediately before and at the end of the spontaneous breathing trial (SBT), assessed up to 2 hours

    Assessment of changes in airway resistance during weaning to evaluate respiratory mechanics at baseline and after the SBT

  5. Change in Intrinsic PEEP

    Time frame: Immediately before and at the end of the spontaneous breathing trial (SBT), assessed up to 2 hours

    Measurement of intrinsic PEEP values before and after the spontaneous breathing trial to assess changes in auto-PEEP during weaning.

  6. Change in Arterial Oxygen Tension (PaO₂)

    Time frame: Immediately before and at the end of the spontaneous breathing trial (SBT), assessed up to 2 hours

    Assessment of PaO₂ changes during weaning to evaluate oxygenation efficiency before and after the spontaneous breathing trial.

  7. Change in Arterial Carbon Dioxide Tension (PaCO₂)

    Time frame: Immediately before and at the end of the spontaneous breathing trial (SBT), assessed up to 2 hours

    Assessment of PaCO₂ changes during weaning to evaluate ventilation efficiency before and after the spontaneous breathing trial.

  8. Extubation Success Rate

    Time frame: Up to 48 hours post-extubation

    Proportion of patients who maintain spontaneous breathing without signs of respiratory distress or hemodynamic instability for 48 hours after extubation. This outcome assesses the overall success of weaning.

Sponsors and collaborators

Lead sponsor

Ain Shams University

Other

Registry information

Official study title

Comparative Study Between Automatic Tube Compensation and Pressure Support Ventilation as a Mode of Weaning From Mechanical Ventilation in Patients With Respiratory Failure

Important dates

Study start
2019
Primary completion
2019
Study completion
2020
First posted
Nov 20, 2025
Registry last updated
Nov 20, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.